The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.
Keyphrases
- public health
- coronavirus disease
- sars cov
- end stage renal disease
- healthcare
- mental health
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- physical activity
- young adults
- patient reported outcomes
- risk assessment
- health information
- climate change
- health insurance
- patient reported
- affordable care act
- smoking cessation